Fas antigen (CD95) can induce apoptosis of cells such as lymphocytes and neutrophils. To determine whether Fas antigen is involved in eosinophil apoptosis, we examined its expression and function on eosinophils in vitro. Purified human eosinophils expressed low but consistently detectable levels of Fas antigen. Culture of eosinophils in up to 10 ngl mL interleukin-5 (IL-5) prolonged eosinophil survival; incorporation of 1 to 1.000 ng/mL Fas antibody led to significant reductions in IL-5-induced eosinophil viability after 48 to 72 hours of culture. Reductions in survival could not be overcome by IL-5 and also occurred in the absence of exogenous IL-5. Preactivation of eosinophils with platelet-activating fac-
Fas antigen (CD95) can induce apoptosis of cells such as lymphocytes and neutrophils. To determine whether Fas antigen is involved in eosinophil apoptosis, we examined its expression and function on eosinophils in vitro. Purified human eosinophils expressed low but consistently detectable levels of Fas antigen. Culture of eosinophils in up to 10 ngl mL interleukin-5 (IL-5) prolonged eosinophil survival; incorporation of 1 to 1.000 ng/mL Fas antibody led to significant reductions in IL-5-induced eosinophil viability after 48 to 72 hours of culture. Reductions in survival could not be overcome by IL-5 and also occurred in the absence of exogenous IL-5. Preactivation of eosinophils with platelet-activating fac-E OSINOPHILS ARE KNOWN to be important effector cells in helminth infections and allergic diseases.',' Several cytokines, including granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (1L)-3, and IL-5, are reported to regulate the development of eosinophils from hematopoietic stem cell^^,^ and support the survival and activation of these cells in When mature peripheral blood eosinophils are cultured in the absence of these cytokines, they undergo apoptosi~.~*'~ Corticosteroids, by inhibiting both the production and actions of these cytokines, also reduce eosinophil numbers and s u r v i~a l . '~"~ Fas antigen or apoptosis antigen-l (APO-l; recently defined as CD95) was first shown to be involved in inducing apoptosis by studies in which cells transfected with Fas antigen displayed accelerated programmed cell death when treated with antibody against this cell surface m01ecule.l~~~~ This molecule has three domains with cysteine-rich residues and is a member of the tumor necrosis factorherve growth factor (TNF/NGF) receptor family that includes two receptors for TNF,",I8 the NGF receptor," CD27," CD30," CD40,*' the MRC OX-40 antigen,z3 and an inducible T-cell antigen termed 4-lBB.'4 All of these molecules are believed to play important roles in regulating cell proliferation and survival." To date, a wide variety of cells and cell lines have been shown to express Fas antigen. These include several malignant cell lines," activated and human immunodeficiency virus (H1V)-infected T cells?' T lymphocytic leukemia cells,28 mature peripheral blood neutrophils and monoc y t e~,~~ and others."' The importance of Fas in vivo is illustrated by the recent recognition that two strains of mice with immunologic disorders-lymphoproliferative disease (Ipr) and generalized lymphoproliferative disorder (gld)-are missing Fas antigen or have a point mutation in the Fas ligand, respectivel~.~"~~ Lymphocytes acquire Fas antigen during differentiation; both direct and indirect evidence suggests that it is important in inducing apoptosis of unwanted lymphocyte^.^^ We hypothesized that human eosinophils might express Fas antigen and, if present, that this molecule may play a role in regulating eosinophil apoptosis. An initial attempt in our laboratoq to detect expression of Fas antigen on peripheral blood eosinophils from a single allergic subject revealed relatively low expre~sion.~~ In the present study, we demonstrate that Fas antigen is consistently expressed on human eosinophils, although at low levels. We found that culture of eosinophils with anti-Fas antibody induces eosinophil apoptosis, even under conditions normally associated with enhanced in vitro eosinophil survival (eg, during coculture with IL-5). Purified eosinophils were suspended in RPMI-1640 medium (GIBCO, Grand Island. NY) supplemented with 10% FCS (HyClone Laboratories, Inc. Logan. UT) and up to 10 nglmL human recombinant IL-S (R&D Systems, Inc. Minneapolis. MN) at a cell density of S X IO'/mL. The cells were cultured in 24-well flat-bottom plates (Costar Corp. Cambridge, MA), previously coated for at least I hour with PBS containing I % BSA. Various concentrations of anti-Fas MoAb ( I to 1.000 nglmL final concentration) or 1 0 0 nglmL anti-CD15 MoAb was added to the cell suspension, and cell viability was examined by a blinded observer by determining trypan blue dye exclusion of at least 200 cells after 24 to 72 hours of culture. In preliminary studies, the trypan blue dye exclusion assay for viability was compared with propidium iodide dye (Sigma) exclusion and fluorescein diacetate (Molecular Probes Inc. Eugene, OR) incorporation. two flow cytometric methods to test cell viability.'.'' An excellent correlation was found between these methods and the trypan blue dye exclusion assay (n = 97. r = ,981, P < , 0 0 1 for fluorescein diacetate and propidium iodide; n = 97, r = ,919. P < ,001 for trypan blue and fluorescein diacetate: and n = 151, r = 396, P < .001 for trypan blue and propidium iodide).
MATERIALS AND METHODS

Monoclonal antibodies (
To examine the effect of eosinophil stimulation on anti-Fas MoAb-induced apoptosis, purified eosinophils were pretreated (30 minutes. 37°C) in Dulbecco's modified Eagle's medium (DMEM: GIRCO) at a cell density of S X IO'lmL with or without moll L platelet-activating factor (PAF Sigma) or 100 ng/mL RANTES (a gift from Dr Tom Schall, Genentech, South San Francisco, CA), and washed twice with PRS-BSA before being cultured for 24 to 72 hours as described above.
DNAfrngmenrnrion m.sn\.. DNA was extracted from eosinophils incubated with or without 1 0 0 nglmL anti-Fas MoAb in the presence of I nglmL IL-S as described7 with slight modifications. Briefly, S X 10" eosinophils were washed twice with TE buffer (10 mmol/L Tris Cl. 1 mmol/L EDTA, pH 8.0; Sigma) and suspended in 400 pL TE buffer containing I % sodium dodecyl sulfate (SDS; Sigma) and 0.2 pglmL proteinase K (BRL Life Technologies Inc. Gaithersburg, MD). After incubation at 37°C for I6 hours, 10 pglmL RNase (Roehringer Mannheim, Indianapolis, IN) was added, and tubes were incubated at 50°C for I hour. DNA was extracted with phenol (Fisher Science, Fair Lawn, NJ) and chloroform (Fisher) and precipitated with 2.S mol/L ammonium acetate and cold ethanol (Sigma). Extracted DNA was dissolved in 50 pL TE buffer, and electrophoresis was performed on a 0.8% agarose gel (BRL Life Technologies) containing 0.0.5 pglmL ethidium bromide (Sigma).
Elecfron microscopic ann1wi.s. Eosinophils were cultured with or without 100 nglmL anti-Fas MoAb in the presence of 1 ng/mL IL-S at 37°C for 60 hours. Cells were washed twice with PBS-BSA, After postfixation staining with l % osmium tetroxide (Ted Pella) for I hour, the cell pellet was stained en bloc with 2% uranyl acetate (Ted Pella) for I hour. After dehydration with a graded series of ethanol (Sigma), the sample was embedded in Spurr's resin at 6°C overnight and dissected by a Reichert Ulticut E (Polysciences, Inc. Warrington. PA) with a diamond knife (low angle, Diatone) at a thickness of 80 nm. The sections were placed on a 200-nm copper grid (Ted Pella), dried, and analyzed by transmission electron microscopy (Carl Zeiss. Inc. Thornwood, NY; TEM model IOA) with 60 kV excitation.
Smtisrics. All data are presented as means 2 SEM. The statistical significance of difference between groups was determined using the Student's 1-test. The separate effects of IL-S, PAF, or RANTES treatment on eosinophil viability and the correlation between these treatments and anti-Fas MoAb treatment were analyzed by two-way analysis of variance (ANOVA; StatView 11, Abacus Concepts Inc. Berkeley, CA).
RESULTS
Expression of Fas antigen on eosinophils. Indirect immunofluorescence and flow cytometry were used to examine Fas expression on eosinophils from six different donors. The flow cytometric histograms of freshly isolated peripheral blood eosinophils from all six donors consistently showed a unimodal peak of staining and were statistically different when compared with an irrelevant IgM control antibody (average mean fluorescence intensities for IgM control and antiFas MoAb were 3.58 5 0.25 and 5.25 t 0.52, respectively: n = 6, P < .02 ; Fig l ) . Similar results were obtained using two additional anti-Fas MoAbs (7C11 and IPO-4"'; data not shown).
Efect cfanti-Fas MoAh on eosinophil viahiliQ. In initial experiments, eosinophils were cocultured with IL-5 To determine the concentration dependence of the anti-Fas MoAb-induced reduction in eosinophil survival, eosinophils were cultured with anti-Fas MoAb (100 ng/mL) and various concentrations of L-5, and eosinophil viability was determined at 48 hours and 72 hours. As shown in Fig 3, in the absence of IL-5, eosinophil viability at 48 hours ( Fig 3A) and 72 hours (Fig 3B) was 26.4% 5 3.9% and 10.3% t 4.8%, respectively. Addition of l to 10,OOO pg/mL of IL-5 into the culture resulted in a concentration-dependent enhancement in eosinophil viability. Viability was significant reduced in the presence of anti-Fas MoAb at all concentrations of IL-5 at both time points. Even the highest concentrations of IL-5 tested (10 ng/mL) did not overcome the reduction in viability caused by anti-Fas MoAb. In addition, anti-Fas MoAb reduced eosinophil survival after 48 hours even in the absence of exogenous IL-5 (Fig 3A) . By 72 hours of culture in the absence of IL-5, viability was too low to detect any effect of anti-Fas MoAb (Fig 3B) . Twoway ANOVA analysis confirmed that the effects of antiFas MoAb treatment and L-5 treatment were independent. Subsequently, this was investigated further by determining whether anti-Fas MoAb, used at various concentrations and examined at an additional earlier time point, could reduce eosinophil viability in the absence of exogenous IL-5. As shown in Fig 4, anti-Fas MoAb used at 100 and 1, OOO ng/ mL significantly reduced eosinophil viability at both 24 hours and 48 hours of culture.
To test whether preactivation altered responsiveness to effects of anti-Fas MoAb, eosinophils were first exposed to 10" m o m PAF or 100 ng/mL RANTES for 30 minutes, washed, and then cocultured in the presence of IL-5 and various concentrations of anti-Fas MoAb (Fig 5) . In the absence of anti-Fas MoAb, PAF treatment reduced eosinophil viability slightly (from 96.9% +-0.9% to 93.3% t 1.5% at 48 hours and from 91.8% 2 2.1% to 84.5% 2 3.1% at 72 hours, for nontreated and PAF-treated cells, respectively). When analyzed by two-way ANOVA, PAF treatment alone significantly reduced eosinophil viability ( P < ,005 at 48 hours; P < . OOO1 at 72 hours), whereas RANTES treatment had no effect (P > .8 at both 48 and 72 hours). However, treatment with either PAF or RANTES did not alter the effects of anti-Fas MoAb treatment. Treatment with PAF (lo" moVL) or RANTES (100 ng/mL) also did not alter the expression of Fas antigen on eosinophils when examined after 30 minutes or 24 hours of culture (data not shown).
Effect of anti-Fas MoAb on eosinophil apoptosis: Examination by electron microscopy and determination of DNA fragmentation. To determine whether the observed reductions in eosinophil viability were the result of apoptosis, several criteria typically used to distinguish apoptosis from necrosis3' were examined. Eosinophils cultured in IL-5 with or without anti-Fas MoAb were harvested after 60 hours, fixed, embedded, stained, and analyzed by electron microscopy. Most of the eosinophils cultured in the presence of both IL-5 and anti-Fas MoAb displayed microscopic changes consistent with apoptosis (eg, karyorrhexis, condensation of nuclear chromatin, blebbing of the cell membrane), while these changes were rarely observed in cells cultured only in IL-5 (Fig 6) . Another characteristic of apoptosis, internucleosoma1 DNA degradation (DNA laddering), was observed after agarose gel electrophoresis of DNA extracted from eosinophils cultured with IL-5 and anti-Fas MoAb for 60 hours (Fig 7) and 36 hours (data not shown), but not from eosinophils cultured with IL-5 alone (Fig 7) .
DISCUSSION
In the present study, human peripheral blood eosinophils were found by indirect immunofluorescence and flow cytometry to have low but detectable surface expression of Fas antigen. Culture with anti-Fas MoAb reduced eosinophil viability in a time-and concentration-dependent manner, both in the presence and absence of exogenously added IL-5. No changes were detected in Fas antigen expression after activation with stimuli such as PAF, even though this stimulus appeared to cause a significant reduction of eosinophil viability. In limited studies, we were unable to find in vitro conditions that altered Fas antigen expression, and no differ- eosinophilia, where eosinophil activation and survival may be altered. As eosinophils contain several types of granule proteins, such as eosinophil major basic protein and eosinophil cationic protein, which can be extremely toxic to a variety of cell types, it is important that pathways exist for inducing eosinophil apoptosis and engulfment without release of granules that could be harmful to the normal tissues of the host. However, whether Fas antigen is involved in eosinophil apoptosis in vivo remains to be determined.
A variety of cytokines are crucial factors in granulocyte development and survival in vitro and in vivo. For eosinophils, IL-3, IL-5, GM-CSF, and perhaps other cytokines serve this role.'" When mature peripheral blood eosinophils are cultured in the absence of these cytokines, they undergo apopto~is.~,'" Corticosteroids, in addition to inhibiting the production of these cytokines, can directly reduce eosinophil survival, although this direct effect can be overcome by increasing the concentration of eosinophil-activating cytokines.I0-l4 This effect differs from that seen with anti-Fas MoAb, where IL-5 could not completely reverse the effects of anti-Fas MoAb (Fig 3) , even at the highest concentrations of IL-5 tested (10 ng/mL). This suggests that the effect of anti-Fas MoAb was not simply to antagonize the effects of IL-5 and that the reduction in L-5-induced eosinophil survival was at least in part mediated through pathways independent of those used by IL-5 to prolong survival. This conclusion was supported by the observation that anti-Fas MoAb also reduced eosinophil survival in the absence of exogenous IL-5 (Figs 3 and 4) . A similar pattern was observed by Wallen et who demonstrated that high concentrations of interferon gamma could not overcome the effects of dexamethasone on eosinophil viability.
The pathway by which anti-Fas MoAb induces eosinophil apoptosis is not clear. Recently, tyrosine kinase activation by anti-Fas MoAb treatment and inhibition of apoptosis by tyrosine kinase inhibitors was reported for a variety of cell lines3' While this aspect of eosinophil apoptosis was not specifically investigated in the present study, our finding that induction of eosinophil apoptosis by anti-Fas MoAb treatment was not simply due to antagonism of IL-5-induced survival is consistent with the concept that signal transduction events are involved in this pathway. Anti-Fas antibody (nglml)
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Despite relatively low levels of Fas antigen expression, required to demonstrate induction of apopto~is.'~.~' Monoanti-Fas MoAb treatment of eosinophils induced apoptosis cytes and neutrophils constitutively express higher levels within 24 to 48 hours. This is in contrast with studies with of Fas antigen, but their susceptibility to anti-Fas MoAblymphocytes, which express similar amounts of Fas antigen mediated apoptosis differs in that neutrophils are more sensibut are less sensitive for the induction of apoptosis by antitive to the treatment than monocytes. The expression of hclFas MoAb treatment, as greater than 4 days of culture is 2, a protooncogene product implicated in cell survival:24
,..W a C".
7 . Fig 6. Electron microscopic analysis of cultured eosinophils. Eosinophils were cultured in l nglmL 11-5 at 37°C for 60 hours in the absence (A; 2,000 x original magnification; viability, 95%) or presence (B and C; viability, 65%; 2,000 x and 6,200 x original magnification, respectively) of 100 ng/mL anti-Fas MoAb and prepared for electron microscopic analysis as described in Materials and Methods In = l). In the presence of antibody, karyorrhexis, nuclear degeneration, and surface membrane swelling are particularly prominent. was shown to be inversely correlated with the susceptibility of these cells to the effect of anti-Fas MoAb treatment. 29 In addition, overexpression of hcl-2 prevents the induction of apoptosis by anti-Fas MoAb treatment."' Therefore, we could speculate that the relative susceptibility of eosinophils to undergo apoptosis by anti-Fas MoAb treatment may be associated with low or absent hcl-2 expression in the cells.
Some of the changes observed in vitro during eosinophil apoptosis, which occurred in the absence of phagocytic cells, may not occur in vivo. For example, it is likely that clearance of apoptotic cells by macrophages is initiated very early in the course of apoptotic cell death?" Thus, several of the processes observed in our in vitro studies, including nuclear fragmentation and cytoplasmic blebbing, may not be observed in tissue sites in vivo. The fact that IL-5 deprivation of eosinophils can lead to eosinophil apoptosis and phagocytosis by macrophages in an in vitro model system' suggests that anti-Fas MoAb treatment may initiate similar pathways of engulfment by macrophages.
Most of the members of the T N F N G F receptor family have soluble ligands in vivo: TNF-(U and TNF-0 for the TNF receptors type I and 11,'' NGF for the NGF receptor, and a new family of cytokines with homology to TNF for CD27.47
In contrast, ligands for CD304' and CD40 ( g~3 9 )~' are cell surface proteins. Recently, a ligand for Fas antigen was repotted as a type I1 transmembrane protein that belongs to the TNF family5' and was found on the surface of cytotoxic T cells.'' In mice, Fas ligand and perforin were shown to contribute to T cell-mediated cytotoxity in vivo.'2 Recently, Fas antigen was found to be constitutively expressed on the cell surface of neutrophils, and treatment with anti-Fas MoAb induced apoptosis."' Collectively, these data suggest that interactions between Fas antigen and Fas ligand in vivo may play an important role in mediating apoptosis of many cell types, including lymphocytes, neutrophils, and eosinophils. For personal use only. on November 16, 2017. by guest www.bloodjournal.org From
